Company / Current Liabilities
IRONWOOD PHARMACEUTICALS INC Current Liabilities History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$242.2M
FY2025
5-year range
$25.5M / $276.1M
FY2021-FY2025
Trend
+523.5%
vs FY2024
Sector context
#54 of 213
Health Care
What the data says
Current Liabilities changed +524% YoY in FY2025, a notable deviation from the 9-year average annual change of +189%.
Based on SEC 10-K filings.
$242M in FY2025 with a 5-year CAGR of +49.7%. Top quartile in the Health Care sector.
Improved from $276M to $242M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +111.7%
- 5-Year CAGR
- +49.7%
- 10-Year CAGR
- -
Sector benchmark
Bottom 25% in Health CareTop 75% of 213This company $242.2M Sector average $1.6B
▼
-84.7% below sector average
Key checks
Key Insights
- 5-year CAGR of +49.7%, indicating consistent growth.
- In FY2025, current liabilities increased 523.5% year-over-year.
- Ranks #54 out of 213 companies in the Health Care sector.
- Peak current liabilities was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score -2.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $242.2M | +523.5% |
| FY2024 | $38.8M | -85.9% |
| FY2023 | $276.1M | +981.7% |
| FY2022 | $25.5M | -84.2% |
| FY2021 | $161.7M | +402.6% |
| FY2020 | $32.2M | -21.4% |
| FY2019 | $40.9M | -65.8% |
| FY2018 | $119.5M | +81.0% |
| FY2017 | $66.0M | -27.5% |
| FY2016 | $91.1M | +19.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026